At this time, New York Oncology Hematology does not have access to acquire and administer the new COVID prophylaxis shot Evusheld for immunocompromised patients. We await further guidance from NYS and will keep our patients updated.

About Us

Dr. Tedesco Explains New Breast Cancer Treatment on Health Beat

11/16/2018

Dr. Tedesco joins health reporter Benita Zahn to discuss NYOH's role in FDA approval of the new breast cancer treatment, Talzenna (talazoparib). Several NYOH patients participated in the trial leading up to approval of the new therapy.